VIA·L
UKRUENES
‹ Усі статті

Цикл після 35: рясніше, рідше, непередбачуваніше — що відбувається

5 хвилин читанняПеревірено спеціалістом VIA-L · 17.10.2026

Місячні то приходять через три тижні, то зникають на два місяці. Стали рясніші й довші, з’явилися згустки. Прокладки не вистачає на ніч. У 35–50 років такі зміни дуже часті — це одна з перших прикмет переходу. Але «часте» не означає «терпіти».

Чому цикл змінюється

У перехідні роки дедалі більше циклів минає без овуляції, і прогестерону стає менше. Естроген у цей час не падає, а гойдається — іноді вище звичного. Звідси й непередбачуваність, і рясніші місячні.

Якщо у вас кільце чи годинник: підйом нічної температури після овуляції вони бачать заднім числом. Якщо підйому в циклі не було, це не означає «мало прогестерону» — після 40 частина циклів просто минає без овуляції.

Що вважати рясним

Рясні місячні часто вважають «моєю особливістю» і роками не перевіряють. Орієнтири:

Рясні місячні й залізо

Рясні місячні — найчастіша причина нестачі заліза в жінок. Запаси заліза падають раніше, ніж змінюється звичайний аналіз крові, і втома, задишка на сходах, випадіння волосся, ламкі нігті, мерзлякуватість з’являються вже тоді. Особливі підказки: тягне гризти лід і ввечері турбують ноги.

Що робити:

І головне: рясні місячні розв’язуються. У гінеколога є варіанти, які знижують крововтрату в рази. Залізо без роботи з причиною — латка, а не рішення.

Відмічати — це половина справи

Відмічайте перший день місячних у VIA-L. За кілька циклів видно, як змінюється довжина циклу, і з цим простіше йти до лікаря. А ще щоденник допомагає зрозуміти, як цикл пов’язаний зі сном, настроєм і припливами.

Що не потрібно

Коли до лікаря без зволікань

Що спробувати цього тижня

На чому ґрунтується

Статтю написано за темами бази знань VIA-L. За ними стоять опубліковані роботи — ось вони:

  1. Cost-Effectiveness of First-Line IV vs Oral Iron for Iron-Deficiency Anemia in Women With Heavy Menstrual Bleeding — Blood Advances, 2026 doi
  2. Cognitive Behavioural Therapeutics for Insomnia Symptoms in the Perimenopause Through to the Early Postmenopausal Period — The Cochrane Database of Systematic Reviews, 2026 doi
  3. Cognitive-Behavioral, Acceptance-Based, and Mindfulness-Based Interventions for Psychological and Sleep-Related Symptoms During Menopause: A Systematic Review — Acta Psychologica, 2026 doi
  4. Integrative Approaches to Perimenopause — The American Journal of Medicine, 2026 doi
  5. Effectiveness of Non-Pharmacological Interventions for Insomnia Related to Natural Menopause: A Meta-Analysis of Randomized Controlled Trials — Maturitas, 2026 doi
  6. Nutritional Modulators of Sleep: A Narrative Review of Vitamins, Minerals, Amino Acids, and Their Neurobiological and Chronoepigenetic Mechanisms — Chronobiology International, 2026 doi
  7. Real-World Safety Profile of Fezolinetant: A Disproportionality Analysis Based on the FAERS Database — Naunyn-Schmiedeberg's Archives of Pharmacology, 2026 doi
  8. Effect of Lactobacillus-Based Probiotics on Genitourinary Syndrome of Menopause in Post-Menopausal Women: A Systematic Review — Maturitas, 2026 doi
  9. Hepatic Adverse Event Signals of Fezolinetant in Real-World Use Based on Postmarketing Surveillance — Obstetrics and Gynecology, 2026 doi
  10. Integrative Medicine Approaches for Menopause — Obstetrics and Gynecology, 2026 doi
  11. Reframing menopause and menopause hormone therapy as opportunities for healthy aging — Science, 2026 doi
  12. Iron Deficiency in Adults: A Review — JAMA, 2025 doi
Показати всі (103)
  1. Psychiatric and Cognitive Outcomes of Iron Supplementation in Non-Anemic Children, Adolescents, and Menstruating Adults: A Meta-Analysis and Systematic Review — Neuroscience and Biobehavioral Reviews, 2025 doi
  2. Comparison of diagnostic algorithms used in guidelines on nutritional anaemias in adults — PloS One, 2025 doi
  3. Infertility Evaluation and Treatment — The New England Journal of Medicine, 2025 doi
  4. Effect of a Novel Nutraceutical Combination of EstroG-100 and Γ-Aminobutyric Acid (GABA) in Attenuating Symptoms of Menopause in Healthy Adult Women: A Randomized Double-Blinded Placebo-Controlled Study — Menopause (New York, N.Y.), 2025 doi
  5. FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes — JAMA, 2025 doi
  6. Nonhormonal Treatment of Menopausal Vasomotor Symptoms — JAMA Internal Medicine, 2025 doi
  7. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial — JAMA Internal Medicine, 2025 doi
  8. Self-Administered Hypnosis vs Sham Hypnosis for Hot Flashes — JAMA Network Open, 2025 doi
  9. Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies — Advances in Therapy, 2025 doi
  10. Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms — Drugs, 2025 doi
  11. Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Advances in Nutrition (Bethesda, Md.), 2025 doi
  12. Evidence-Based Guideline: Premature Ovarian Insufficiency — Fertility and Sterility, 2025 doi
  13. The Effectiveness of Mindfulness-Based Interventions on Menopausal Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Journal of Affective Disorders, 2025 doi
  14. The Role of Lifestyle Medicine in Menopausal Health: A Review of Non-Pharmacologic Interventions — Climacteric : The Journal of the International Menopause Society, 2025 doi
  15. European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause — European Journal of Endocrinology, 2025 doi
  16. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-Analysis — Obstetrics and Gynecology, 2025 doi
  17. Gut Microbiota Has the Potential to Improve Health of Menopausal Women by Regulating Estrogen — Frontiers in Endocrinology, 2025 doi
  18. Natural Strategies to Optimize Estrogen Levels in Aging Women: Mini Review — Frontiers in Aging, 2025 doi
  19. Effects of Soy Isoflavones on Menopausal Symptoms in Perimenopausal Women: A Systematic Review and Meta-Analysis — PeerJ, 2025 doi
  20. The Modern Management of Uterine Fibroids-Related Abnormal Uterine Bleeding — Fertility and Sterility, 2024 doi
  21. ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update — Journal of the American College of Radiology : JACR, 2024 doi
  22. A clinical study evaluating low dose ferrous fumarate vs — Scientific Reports, 2024 doi
  23. Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update — British Journal of Haematology, 2024 doi
  24. An Empowerment Model for Managing Menopause — Lancet (London, England), 2024 doi
  25. "Not feeling like myself" in perimenopause - what does it mean? Observations from the Women Living Better survey — Menopause, 2024 doi
  26. Mapping Global Prevalence of Menopausal Symptoms Among Middle-Aged Women: A Systematic Review and Meta-Analysis — BMC Public Health, 2024 doi
  27. The Relationship Between Heavy Menstrual Bleeding, Iron Deficiency, and Iron Deficiency Anemia — American Journal of Obstetrics and Gynecology, 2023 doi
  28. Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas — Obstetrics and Gynecology, 2023 doi
  29. Oral Micronized Progesterone for Perimenopausal Night Sweats and Hot Flushes a Phase III Canada-Wide Randomized Placebo-Controlled 4 month Trial — Scientific Reports, 2023 doi
  30. Effects of Sleep Fragmentation and Estradiol Decline on Cortisol in a Human Experimental Model of Menopause — The Journal of Clinical Endocrinology and Metabolism, 2023 doi
  31. Changes in Cortisol Awakening Responses (CAR) in Menopausal Women Through Short-Term Marine Healing Retreat Program With Specific Factors Affecting Each CAR Index — PloS One, 2023 doi
  32. Progesterone and Its Metabolites Play a Beneficial Role in Affect Regulation in the Female Brain — Pharmaceuticals (Basel, Switzerland), 2023 doi
  33. Management of Menopausal Symptoms: A Review — JAMA, 2023 doi
  34. Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms — JAMA Network Open, 2023 doi
  35. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review — Archives of Gynecology and Obstetrics, 2023 doi
  36. Fezolinetant: First Approval — Drugs, 2023 doi
  37. EMAS Position Statement: Vitamin D and Menopausal Health — Maturitas, 2023 doi
  38. Resistance Training for Postmenopausal Women: Systematic Review and Meta-Analysis — Menopause (New York, N.Y.), 2023 doi
  39. A Dietary Intervention for Vasomotor Symptoms of Menopause: A Randomized, Controlled Trial — Menopause (New York, N.Y.), 2023 doi
  40. Black Cohosh Extracts in Women With Menopausal Symptoms: An Updated Pairwise Meta-Analysis — Menopause (New York, N.Y.), 2023 doi
  41. The 2023 Nonhormone Therapy Position Statement of the North American Menopause Society — Menopause (New York, N.Y.), 2023 doi
  42. Rethinking Menopausal Hormone Therapy: For Whom, What, When and How long? — Circulation, 2023 doi
  43. Effect of hysterectomy on ovarian function: a systematic review and meta-analysis — J Ovarian Res, 2023 doi
  44. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis — Cochrane Database of Systematic Reviews, 2022 doi
  45. Iron Deficiency Anemia: Impact on Women's Reproductive Health — Fertility and Sterility, 2022 doi
  46. Uterine bleeding: how understanding endometrial physiology underpins menstrual health — Endocrinology, 2022 doi
  47. Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children — British Journal of Haematology, 2022 doi
  48. Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action — Journal of Internal Medicine, 2022 doi
  49. Relating Neurosteroid Modulation of Inhibitory Neurotransmission to Behaviour — Journal of Neuroendocrinology, 2022 doi
  50. Role of Inflammation, Oxidative Stress, and Mitochondrial Changes in Premenstrual Psychosomatic Behavioral Symptoms with Anti‐Inflammatory, Antioxidant Herbs, and Nutritional Supplements — Oxidative Medicine and Cellular Longevity, 2022 doi
  51. Efficacy of Cognitive Therapy and Behavior Therapy for Menopausal Symptoms: A Systematic Review and Meta-Analysis — Psychological Medicine, 2022 doi
  52. Effects of Exercise on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis — Climacteric : The Journal of the International Menopause Society, 2022 doi
  53. Results of a Pilot Study of a Cooling Mattress Pad to Reduce Vasomotor Symptoms and Improve Sleep — Menopause (New York, N.Y.), 2022 doi
  54. Resistance Training Reduced Luteinising Hormone Levels in Postmenopausal Women in a Substudy of a Randomised Controlled Clinical Trial: A Clue to How Resistance Training Reduced Vasomotor Symptoms — PloS One, 2022 doi
  55. A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anemia in Women With Heavy Menstrual Bleeding — Advances in Therapy, 2021 doi
  56. Diagnosis and Treatment of Luteal Phase Deficiency: A Committee Opinion — Fertility and Sterility, 2021 doi
  57. The Effect of Vitamin MK-7 on Bone Mineral Density and Microarchitecture in Postmenopausal Women With Osteopenia, a 3-Year Randomized, Placebo-Controlled Clinical Trial — Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021 doi
  58. Cognitive Behavioral Therapy for Menopausal Symptoms — Climacteric : The Journal of the International Menopause Society, 2021 doi
  59. Assessment and Management of Heavy Menstrual Bleeding — JAMA, 2020 doi
  60. The Allopregnanolone to Progesterone Ratio Across the Menstrual Cycle and in Menopause — Psychoneuroendocrinology, 2020 doi
  61. The Effects of Dietary Nutrition on Sleep and Sleep Disorders — Mediators of Inflammation, 2020 doi
  62. The Effect of Oral Capsule of Curcumin and Vitamin E on the Hot Flashes and Anxiety in Postmenopausal Women: A Triple Blind Randomised Controlled Trial — Complementary Therapies in Medicine, 2020 doi
  63. Altered Activity of Xenobiotic Detoxifying Enzymes at Menopause - A Cross-Sectional Study — Environmental Research, 2020 doi
  64. Calcium, Vitamin D, Vitamin K2, and Magnesium Supplementation and Skeletal Health — Maturitas, 2020 doi
  65. Hormone Therapy for Postmenopausal Women — The New England Journal of Medicine, 2020 doi
  66. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association — Circulation, 2020 doi
  67. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update — Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2020 doi
  68. Abnormal Uterine Bleeding in Reproductive-Age Women — JAMA, 2019 doi
  69. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785 — Obstetrics and Gynecology, 2019 doi
  70. Allopregnanolone and Reproductive Psychiatry: An Overview — International Review of Psychiatry (Abingdon, England), 2019 doi
  71. Soy Intake and Vasomotor Menopausal Symptoms Among Midlife Women: A Pooled Analysis of Five Studies From the InterLACE Consortium — European Journal of Clinical Nutrition, 2019 doi
  72. Pheochromocytoma and Paraganglioma — The New England Journal of Medicine, 2019 doi
  73. Antifibrinolytics for heavy menstrual bleeding — Cochrane Database of Systematic Reviews, 2018 doi
  74. Effect of Omega-3 Supplements on Vasomotor Symptoms in Menopausal Women: A Systematic Review and Meta-Analysis — European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2018 doi
  75. Mindfulness-Based Stress Reduction (MBSR) or Psychoeducation for the Reduction of Menopausal Symptoms: A Randomized, Controlled Clinical Trial — Scientific Reports, 2018 doi
  76. Why Are Women So Vulnerable to Anxiety, Trauma-Related and Stress-Related Disorders? The Potential Role of Sex Hormones — Psychiatry, 2017 doi
  77. Effects of low‐to‐moderate alcohol supplementation on urinary estrogen metabolites in postmenopausal women in a controlled feeding study — Cancer Medicine, 2017 doi
  78. Surgery versus medical therapy for heavy menstrual bleeding — Cochrane Database of Systematic Reviews, 2016 doi
  79. Non‐anaemic iron deficiency – a disease looking for recognition of diagnosis: a systematic review — European Journal of Haematology, 2016 doi
  80. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis — JAMA, 2016 doi
  81. Duration of menopausal vasomotor symptoms over the menopause transition — JAMA Intern Med, 2015 doi
  82. Luteal Phase Deficiency in Regularly Menstruating Women: Prevalence and Overlap in Identification Based on Clinical and Biochemical Diagnostic Criteria — The Journal of Clinical Endocrinology and Metabolism, 2014 doi
  83. Exercise for vasomotor menopausal symptoms — Cochrane Database of Systematic Reviews, 2014 doi
  84. Fruit, Mediterranean-Style, and High-Fat and -Sugar Diets Are Associated With the Risk of Night Sweats and Hot Flushes in Midlife: Results From a Prospective Cohort Study — The American Journal of Clinical Nutrition, 2013 doi
  85. Practice Bulletin No — Obstetrics and Gynecology, 2012 doi
  86. Protective role of melatonin in progesterone production by human luteal cells — Journal of Pineal Research, 2011 doi
  87. Perceived Control, Lifestyle, Health, Socio-Demographic Factors and Menopause: Impact on Hot Flashes and Night Sweats — Maturitas, 2011 doi
  88. Pathophysiology and Treatment of Menopausal Hot Flashes — Seminars in Reproductive Medicine, 2005 doi
  89. Is This Woman Perimenopausal? — JAMA, 2003 doi
  90. Diagnostic Role of Follicle-Stimulating Hormone (FSH) Measurements During the Menopausal Transition--an Analysis of FSH, Oestradiol and Inhibin — European Journal of Endocrinology, 1994 doi
  91. The Association Between Moderate Alcoholic Beverage Consumption and Serum Estradiol and Testosterone Levels in Normal Postmenopausal Women: Relationship to the Literature — Alcoholism, Clinical and Experimental Research, 1992 doi

Доказова сила цих робіт різна: десь великі огляди та мета-аналізи, десь окремі невеликі дослідження. Кроки в статті — прості заходи турботи про себе з низьким ризиком, а не лікування, і підходять не всім.

Це загальні відомості, а не призначення. Обстеження й лікування підбирає лікар.

Застосунок VIA-L

VIA-L — застосунок для жінок від 35 і чоловіків від 40 років: сон, енергія, настрій і тіло в період гормональних змін. Простими словами, за вашими даними — і з перевіркою, що допомогло.

Усі статті бібліотеки є й у застосунку.

App StoreGoogle Play

Читати далі

Припливи: чому вони бувають і що насправді допомагає4 хвилини читанняЧому після 40 псується сон і що з цим робити5 хвилин читанняЗвідки береться втома після 40 і як повернути сили5 хвилин читання